TM9SF4 expression in tumor tissues: a novel diagnostic biomarker for gastrointestinal tumors.

Abstract

BACKGROUND:

The identification of novel biomarkers for the early detection and monitoring of gastric (GC) and colorectal cancer (CRC) is of paramount importance. TM9SF4 is a newly described V-ATPase interacting protein involved in the malignant progression of cancer cells. While TM9SF4 expression pattern and cellular localization have been described in in vitro in tumor cell lines of different histotypes, its expression in gastrointestinal tumor tissues has never been investigated.

METHODS:

In this study, we detected by immunohistochemistry (IHC) in tumor and surrounding healthy tissues TM9SF4, in comparison with clinically adopted biomarkers CEA and CA 19-9 to evaluate TM9SF4 potential as a novel tissue marker for early detection and monitoring of GC and CRC cancers.

RESULTS:

The expression of TM9SF4, CEA and CA 19-9 was evaluated in samples from 108 cancer patients (68 with GC and 40 CRC) and in healthy tissues from 20 non-cancer patients. Our results clearly suggest that TM9SF4 expression was significantly increased in GC and CRC samples and significantly correlated to disease stage in both cancer types.

CONCLUSIONS:

We propose TM9SF4 as highly specific cancer biomarker, exploitable for disease detection and staging of gastrointestinal cancers patients, with tumor tissue levels of expression outperforming those of clinically adopted markers such as CEA and CA 19-9.

• Authors: Paolo Guazzi, Davide Zocco, Sergejs Isajevs, Natasa Zarovni, Laura Bianciardi, Mart Toots, Armands Sivins, Marcis Leja, Antonio Chiesi, Francesco Lozupone
• Journal: Translational cancer research (Transl Cancer Res) Vol. 9 Issue 11 Pg. 6652-6659 (Nov 2020) ISSN: 2219-6803 [Electronic] China
• PMID: 35117275 (Publication Type: Journal Article)
• Copyright: 2020 Translational Cancer Research. All rights reserved.